Sort
8,912 grants matching “sars cov 2”
Peripheral Tissue Biomarker for Premorten Diagnosis of Lewy Body Dementia
$975,214Shu G Chen · Case Western Reserve University · R01 · FY2021 · NS
Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome
$975,000Nuala Jennings Meyer · University Of Pennsylvania · R35 · FY2025 · HL
Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome
$975,000Nuala Jennings Meyer · University Of Pennsylvania · R35 · FY2022 · HL
Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome
$975,000Nuala Jennings Meyer · University Of Pennsylvania · R35 · FY2023 · HL
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$974,635Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
THE COVID-19 PANDEMIC HAS DISPERSED A NEW STRAIN OF CORONAVIRUS (CALLED SARS-COV-2) THROUGHOUT THE WORLD. DURING THE RAPID GLOBAL SPREAD, THE NEW VIRUS CONTINUES TO MUTATE AND THERE ARE NOW NUMEROUS GENETIC VERSIONS OF SARS-COV-2. THE U.S. LIVESTOCK SECTOR PLAYS AN INDISPENSABLE ROLE IN THE SAFE AND RELIABLE FOOD SUPPLY, EMPLOYMENT, AND ECONOMIC DEVELOPMENT, SO IT IS CRITICAL TO UNDERSTAND IF SARS-COV-2 VIRUSES CAN POSE A THREAT TO LIVESTOCK. THE GOALS OF THIS PROJECT ARE TO INVESTIGATE THE SUSCEPTIBILITY OF LIVESTOCK TO SARS-COV-2 AND TO DETERMINE IF THE VIRUS MAY ADAPT AND EFFICIENTLY SPREAD AMONG LIVESTOCK. THE RESEARCH WILL USE A COMBINATION OF EXPERIMENTAL INFECTION STUDIES USING CELL CULTURES AND ANIMALS ALONG WITH COMPUTER MODELS TO ASSESS THE CHANCE FOR THE VIRUS TO EFFICIENTLY INFECT LIVESTOCK SPECIES. ADDITIONALLY, THE PROJECT WILL DEVELOP DIAGNOSTIC TESTS AND USE THEM TO MONITOR THE PRESENCE OF ANTIBODIES TO SARS-COV-2 IN LIVESTOCK ANIMALS. CHICKENS, CATTLE, AND PIGS ARE MAJOR ANIMAL AGRICULTURE SPECIES IN THE U.S., AND THROUGH THIS PROJECT, A BETTER UNDERSTANDING OF HOW SARS-COV-2 MAY AFFECT THEM WILL BE GAINED.
$974,311The Pennsylvania State University · · FY2020 · National Institute of Food and Agriculture
THE WORLD IS FACING A CRISIS DUE TO THE COVID-19 PANDEMIC, WHICH HAS RESULTED IN THE CLOSURE OF MANY BUSINESSES. FOOD SUPPLY CHAIN PERSONNEL FROM FARM TO RETAIL LEVELS DO NOT HAVE THIS OPPORTUNITY TO WORK FROM HOME. MEANWHILE, KEEPING ALL WORKERS IN THE FOOD SUPPLY CHAINS HEALTHY AND SAFE IS CHALLENGING FOR STAKEHOLDERS. OUR KNOWLEDGE ABOUT SARS-COV-2 SURVIVAL ON FOODS, AND FOOD CONTACT SURFACES, AND IN RESPONSE TO DIFFERENT DISINFECTION METHODS, IS VERY LIMITED. IN ADDITION, THE FATE OF VIRUS AND HOW IT CAN BE TRANSFERRED THROUGH THE FOOD SUPPLY CHAIN HAS NOT BEEN ADDRESSED YET. THUS, THESE SIGNIFICANT LIMITATIONS HIGHLIGHTED THE UNMET NEEDS TO DEVELOP SYSTEMATIC RESEARCH APPROACHES, AND TRAINING MATERIALS FOR INDUSTRY. THE SPECIFIC AIMS OF THIS PROPOSED RESEARCH ARE: (A) ASSESS SURVIVAL OF SARS-COV-2 ON DIFFERENT FOODS, FOOD CONTACT SURFACES, AND PACKAGING MATERIALS UNDER DIFFERENT CONDITIONS; (B) DETERMINE THE EFFICACY OF DIFFERENT CONVENTIONALLY USED AND NOVEL SANITIZERS AGAINST SARS-COV-2 ON FOOD AND FOOD CONTACT SURFACES; (C) MEASURE THE TRANSFER RATE FROM HANDS TO FOODS AND FOOD CONTACT SURFACES TO BEST MIMIC THE FATE OF VIRUS; (D) DEVELOP EDUCATION MATERIALS FOR FOOD SUPPLY CHAIN STAKEHOLDERS, INCLUDING FARMERS, FOOD PRODUCTION WORKERS, FOOD RETAILERS AND CONSUMERS. BASED ON THIS SYSTEMATIC APPROACH, ADOPTABLE STRATEGIES WILL BE DEVELOPED ACROSS THE FOOD AND AGRICULTURE INDUSTRY TO RAPIDLY RESPOND TO THE COVID-19 PANDEMIC.
$972,188Virginia Polytechnic Institute & State University · · FY2020 · National Institute of Food and Agriculture
IN VITRO TESTING IN HUMAN CELL LINES FOR ANTIMICROBIAL ACTIVITY AGAINST SARS-COV-2
$971,739Sara Cherry · University Of Pennsylvania · N02 · FY2021 · AI
Core-002
$971,739Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2025 · AI
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination
$971,500Pamela J Bjorkman · Rockefeller University · P01 · FY2023 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$970,881Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Cerebrospinal Fluid in PASC: A Window into the COVID Mind
$970,664Serena S Spudich · Yale University · R01 · FY2022 · MH
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
$969,746Ted Ross · University Of Georgia · N01 · FY2020 · AI
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
$969,655Ted Ross · University Of Georgia · N01 · FY2020 · AI
RNA: New Antimicrobial Strategies
$969,159Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
MPOPHC: Quantitative design of effective testing-based policies through infection trajectory modeling
$968,765Stephen Kissler · University Of Colorado At Boulder · · FY2025 · MPS
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
$968,643Joanna B. Goldberg · Emory University · R01 · FY2024 · AI
The economic and social impact of COVID-19 mitigation policies: A cross-country analysis of macro events
$968,248Dean R Lillard · Ohio State University · R01 · FY2024 · AG
Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health during the Pandemic
$968,064Michael J Zvolensky · University Of Houston · R01 · FY2022 · MH
CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3
$967,373Jonathan L Temte · University Of Wisconsin-Madison · U01 · FY2021 · CK
Broadly neutralizing SARS-CoV-2 peptidic knobs
$967,225Vaughn Vasil Smider · Applied Biomedical Science Institute · R01 · FY2023 · AI
Project 4: Computational panbetaCoV immunogen design
$966,626Rory Henderson · Duke University · P01 · FY2023 · AI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$966,453John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2023 · GM
Culturally-targeted communication to promote SARS-CoV-2 antibody testing in saliva: Enabling evaluation of inflammatory pathways in COVID-19 racial disparities
$964,759Todd William Lucas · Michigan State University · U01 · FY2023 · CA
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$963,672Yogen Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL